Comment on

• High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

  Schavgoulidze A, Perrot A, Leleu X, Cazaubiel T, Chretien ML, Feugier P, Belhadj K, Manier S, Roussel M, Brechignac S, Orsini-Piocelle F, Mohty M, Schiano de Collela JM, Macro M, Adiko D, Dib M, Fontan J, Luttiau-Motard C, Bouscary D, Pascal L, Roland V, Lifermann F, Bakala J, Montes L, Kennel C, Rey P, Richez V, Keddar F, Frenzel L, Calmettes C, Chaleteix C, Plantier I, Chalayer E, Schmitt A, Roul C, Demarquette H, Cerutti C, Pavageau L, Derrier L, Avet-Loiseau H, Corre J. Schavgoulidze A, et al. Blood. 2026 Jan 15;147(3):266-275. doi: 10.1182/blood.2025029999. Blood. 2026. PMID: 40991836